Form D Explorer

Inspect source fieldsReport a record issue

Form D — RECODE THERAPEUTICS, INC.

0000905148-25-003655 · filed Oct 23, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$29,441,931
Reported amount sold
$29,441,931
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
RECODE THERAPEUTICS, INC.
CIK
1693764
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
1140 O'Brien Drive
Menlo Park, California 94025
Phone
408-585-1700

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗